TIAM1 acts as an actin organization regulator to control adipose tissue–derived pericyte cell fate
JCI Insight · 2023
DOI: 10.1172/jci.insight.159141 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCI Insight, 2023. Verfasst von Ginny Ching-Yun Hsu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Johns Hopkins University, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Actins, Pericytes. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS, NIDCR NIH HHS, National Institutions of Health.
Abstract (Originalsprache)
Pericytes are multipotent mesenchymal precursor cells that demonstrate tissue-specific properties. In this study, by comparing human adipose tissue– and periosteum-derived pericyte microarrays, we identified T cell lymphoma invasion and metastasis 1 (TIAM1) as a key regulator of cell morphology and differentiation decisions. TIAM1 represented a tissue-specific determinant between predispositions for adipocytic versus osteoblastic differentiation in human adipose tissue–derived pericytes. TIAM1 overexpression promoted an adipogenic phenotype, whereas its downregulation amplified osteogenic differentiation. These results were replicated in vivo, in which TIAM1 misexpression altered bone or adipose tissue generation in an intramuscular xenograft animal model. Changes in pericyte differentiation potential induced by TIAM1 misexpression correlated with actin organization and altered cytoskeletal morphology. Small molecule inhibitors of either small GTPase Rac1 or RhoA/ROCK signaling reversed TIAM1-induced morphology and differentiation in pericytes. In summary, our results demonstrate that TIAM1 regulates the cellular morphology and differentiation potential of human pericytes, representing a molecular switch between osteogenic and adipogenic cell fates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Johns Hopkins University, Baltimore, Maryland, USA.
- Department of Orthodontics, Oregon Health & Science University, Portland, Oregon, USA.
- Department of Plastic Surgery, Johns Hopkins University, Baltimore, Maryland, USA.
- UCLA and Orthopaedic Hospital Department of Orthopaedic Surgery and Orthopaedic Hospital Research Center, Los Angeles, California, USA.
- Center for Cardiovascular Sciences, University of Edinburgh, Edinburgh, United Kingdom.
- Department of Orthopaedic Surgery, Johns Hopkins University, Baltimore, Maryland, USA.
Förderung
- NIAMS NIH HHS
- NIDCR NIH HHS
- National Institutions of Health
- US Army Medical Research Acquisition Activity
- American Cancer Society
Zitieren
APA
Hsu, G. C., Wang, Y., Lu, A. Z., Gomez-Salazar, M. A., Xu, J., Li, D., Meyers, C., Negri, S., Wangsiricharoen, S., Broderick, K., Peault, B., Morris, C., & James, A. W. (2023). TIAM1 acts as an actin organization regulator to control adipose tissue–derived pericyte cell fate. JCI Insight. https://doi.org/10.1172/jci.insight.159141
Vancouver
Hsu GC, Wang Y, Lu AZ, Gomez-Salazar MA, Xu J, Li D, et al. TIAM1 acts as an actin organization regulator to control adipose tissue–derived pericyte cell fate. JCI Insight. 2023. doi:10.1172/jci.insight.159141
BibTeX
@article{Hsu2023,
author = {Hsu, Ginny Ching-Yun and Wang, Yiyun and Lu, Amy Z and Gomez-Salazar, Mario A and Xu, Jiajia and Li, Dongqing and Meyers, Carolyn and Negri, Stefano and Wangsiricharoen, Sintawat and Broderick, Kristen and Peault, Bruno and Morris, Carol and James, Aaron W},
title = {TIAM1 acts as an actin organization regulator to control adipose tissue–derived pericyte cell fate},
journal = {JCI Insight},
year = {2023},
doi = {10.1172/jci.insight.159141}
}
EUVIMED